Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants
Description
[This corrects the article DOI: 10.3389/fimmu.2021.761250.].
